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Introduction
Approximately 1 in 500 to 1 in 635 women will require non-ob-
stetrical abdominal surgery during their pregnancies [1, 2]. The 
most common non-obstetrical surgical emergencies complicating 
pregnancy are acute appendicitis, cholecystitis, and intestinal ob-
struction [1]. Other conditions that may require operations during 
pregnancy include ovarian cysts, masses or torsion, symptomatic 
cholelithiasis, adrenal tumors, splenic disorders, symptomatic 
hernias, complications of  inflammatory bowel diseases, and ab-
dominal pain of  unknown etiology. During its infancy, some ar-
gued that laparoscopy was contraindicated during pregnancy due 
to concerns for uterine injury and fetal perfusion. As surgeons 
have gained more experience with laparoscopy it has become the 
preferred modality of  treatment for many surgical diseases in the 
gravid patient [3].
Indications
“Laparoscopic treatment of  acute abdominal disease has the same indications 
in pregnant and non-pregnant patients”
Once the decision to operate has been made, the surgical approach 
(laparotomy versus laparoscopy) should be determined based on 
the skills of  the surgeon and the availability of  the appropriate 
staff  and equipment. An appropriate discussion with the patient 
regarding the risks and benefits of  surgical intervention should 
be undertaken. Benefits of  laparoscopy during pregnancy appear 
similar to those benefits in non-pregnant patients including less 
postoperative pain, less postoperative ileus, decreased length of  
hospital stays and faster return to work [4, 6, 8-10].
Laparoscopy and Pregnancy related risk
“Laparoscopy can be safely performed regardless of  any trimester of  preg-
nancy”
Operative intervention may be performed in any trimester of  
pregnancy.  Historical recommendations were to delay surgery un-
til the second trimester in order to reduce the rates of  spontane-
ous abortion and preterm labor [11]. Recent literature has shown 
that pregnant patients may undergo laparoscopic surgery safely 
during any trimester without any increased risk to the mother or 
fetus [4, 10, 12, 15]. Postponing necessary operations until after 
parturition may, in some cases, increase the rates of  complications 
for both mother and fetus [12, 16].
It has been suggested that the gestational age limit for successful 
completion of  laparoscopic surgery during pregnancy is 26 to 28 
weeks [5]. This has been refuted by several studies in which lapa-
roscopic cholecystectomy and appendectomy have been success-
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fully performed late in the third trimester [13, 15, 17, 18].
Although laparoscopy can be performed safely in pregnancy with 
good fetal and maternal outcomes, the long-term effects to the 
children have not been well studied. One recent study evaluated 
eleven children from one to eight years and found no growth or 
developmental delay [7].
There are many advantages of  laparoscopy in the pregnant patient 
including: decreased fetal respiratory depression due to dimin-
ished postoperative narcotic requirements [6, 19, 20], lower risk 
of  wound complications [19, 21, 22], diminished postoperative 
maternal hypoventilation [19, 20], and decreased risk of  throm-
boembolic events. The improved visualization in laparoscopy may 
reduce the risk of  uterine irritability by decreasing the need for 
uterine manipulation [23]. Decreased uterine irritability results in 
lower rates of  spontaneous abortion and preterm delivery [24].
Pre-anaesthetic assessment and optimization
Many signs and symptoms often associated with cardiac disease, 
such as dyspnoea, heart murmurs and peripheral oedema are 
common during normal pregnancy. ECG changes during preg-
nancy include left axis deviation, premature beats and non-spe-
cific ST and T-wave changes. During radiological investigations, 
fetal exposure should be minimized. Results of  relevant blood 
tests should be available and cross - matched blood must be or-
dered for all major surgery. Pre-medication should always include 
aspiration prophylaxis such as ranitidine, sodium citrate and me-
toclopramide. Aspiration prophylaxis is recommended from the 
beginning of  the second trimester.
Intraoperative considerations
The anaesthesiologist has the following goals inside operating 
room [25]
1. Optimize and maintain normal maternal physiological func-
tion;
2. Optimize and maintain utero-placental blood flow and oxy-
gen delivery;
3. Avoid unwanted drug effects on the fetus;
4. Avoid stimulating the myometrium (oxytocic effects);
5. Avoid awareness during general-anaesthesia.
Resuscitation, if  required, should be vigorously performed fol-
lowing the usual advanced life support (ACLS) or advanced trau-
ma life support (ATLS) protocols, with the addition of  left lateral 
tilt to avoid supine hypotension.
Airway management by a face mask, a laryngeal mask or tracheal 
intubation can be technically difficult because of  increased an-
teroposterior chest wall diameter, breast enlargement, laryngeal 
oedema and weight gain affecting the soft tissues of  the neck. 
Nasal tube airways should be avoided in pregnancy because of  
increased vascularity of  mucous membranes.
Analgesia should be prescribed where appropriate to avoid the 
detrimental effects of  stress to the mother and fetus. Non-steroi-
dal anti-inflammatory drugs should be avoided, because of  the 
risk of  premature closure of  the ductus arteriosus. However, low 
dose aspirin, even when taken regularly, appears safe in this re-
spect.
Pregnancy is associated with lower anaesthetic requirements, al-
though the mechanism for this is unknown. The minimum al-
veolar concentration (MAC) for inhalation anaesthetics is reduced 
by 30% as early as 8–12 weeks gestation. IV drugs that induce 
general anaesthesia should also be given in lower doses. Choice 
among IV induction agents in pregnancy is a controversy, since 
we are looking for a safest available drug in pregnant patient un-
dergoing surgery choice would be based on benefits mother and 
fetus outweighs risk or side effects related with its use. In author’s 
opinion, thiopentone sodium being a hydrophilic drug has mini-
mal permeability to placental barrier matches most of  it. Nitrous 
oxide is avoided as animal studies provide evidence that it is a 
potent inhibitor of  methionine synthase. In addition to it may fur-
ther exacerbate the hypoxemia caused because of  C02 insufflation 
intraperitoneally. Marked reduction of  plasma cholinesterase con-
centration (30% reduction) theoretically causes succinylcholine, 
ester local anaesthetics and certain other drugs to have prolonged 
effects. However, this is counterbalanced by increased volumes 
for drug distribution. Therefore, it is of  consequence, if  at all, in 
the postpartum period, when enzyme activity remains depressed 
but the volume of  distribution begins to normalize. Among non 
depolarizing muscle relaxants, vecuronium and cisatracurium are 
better options of  choice devoid of  vagolytic and histamine releas-
ing properties. Neuromuscular drug monitoring is recommended.
Patient Positioning
Aortocaval compression is a major hazard from 20 weeks on-
wards (and sometimes even earlier); when the pregnant patient is 
placed in a supine position, the gravid uterus places pressure on 
the inferior vena cava resulting in decreased venous return to the 
heart. This decrease in venous return results in significant reduc-
tion in cardiac output with concomitant maternal hypotension, 
and decreased placental perfusion during surgery [26, 27]. This 
effect may be exacerbated by regional or general anaesthesia when 
normal compensatory mechanisms are attenuated or abolished. 
Aortocaval compression is only effectively avoided by the use of  
the lateral position. It can be decreased by uterine displacement 
through wedging or manual displacement. Placing the patient in 
a left lateral decubitus position will shift the uterus off  the vena 
cava improving venous return and cardiac output.
Insufflation Pressure
The potential for adverse consequences from CO2 insufflation in 
the pregnant patient has led to apprehension over its use. As such, 
some authors advocate gasless laparoscopy in pregnant patients, 
but this technique not been widely adopted [28-30].
The pregnant patient’s diaphragm is upwardly displaced by the 
growing fetus, which results in decreased residual lung volume 
and functional residual capacity [31]. Upward displacement of  the 
diaphragm by pneumoperitoneum is more worrisome in a preg-
nant patient with existing restrictive pulmonary physiology. Some 
have recommended intra abdominal insufflation pressures be 
maintained at less than 12 mmHg to avoid worsening pulmonary 
physiology in gravid women [32]. Others have argued that insuf-
flation less than 12 mmHg may not provide adequate visualization 
of  the intra-abdominal cavity. Pressures of  15 mmHg have been 
used during laparoscopy in pregnant patients without increasing 
adverse outcomes to the patient or her fetus [13, 15].
Because CO2 exchange occurs with intraperitoneal insufflation 
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there has been concern for deleterious effects to the fetus from 
pneumoperitoneum. Some animal studies have confirmed fetal 
acidosis with associated tachycardia, hypertension and hypercap-
noea during CO2 pneumoperitoneum [33, 34], while other animal 
studies contradict these findings [35]. There are no data showing 
detrimental effects to human fetuses from CO2 pneumoperito-
neum [5].
Intra-operative CO2 Monitoring (capnography)
Fetal acidosis and associated fetal instability in CO2 pneumoperi-
toneum have been documented in animal studies, though no long-
term effects from these changes have been identified [33, 36]. Fetal 
acidosis with insufflation has not been documented in the human 
fetus, but concerns over potential detrimental effects of  acidosis 
have led to the recommendation of  maternal CO2 monitoring [38, 
39]. Initially, there was debate over maternal blood gas monitoring 
of  arterial carbon dioxide (PaCO2) versus end-tidal carbon diox-
ide (ETCO2) monitoring, but the less invasive capnography has 
been demonstrated to adequately reflect maternal acid-base status 
in humans [39]. Several large studies have documented the safety 
and efficacy of  EtCO2 measurements in pregnant women [5, 13, 
15] making routine blood gas monitoring unnecessary.
Venous Thromboembolic (VTE) Prophylaxis
Pregnancy is associated with a hypercoagulable state because of  
increased pro-coagulant factors. The incidence of  thromboem-
bolic complications is at least five times greater during pregnancy 
with a 0.1-0.2% incidence of  deep venous thrombosis [40]. CO2 
pneumoperitoneum may increase the risk of  deep venous throm-
bosis by predisposing to venous stasis. Insufflation of  12 mmHg 
causes a significant decrease in blood flow that cannot be com-
pletely reversed with intermittent pneumatic compression devices 
or intermittent electric calf  stimulators [41].
Although there is little research on prophylaxis for deep venous 
thrombosis in the pregnant patient, general principles for laparo-
scopic surgery apply. Because of  the increased risk of  thrombosis, 
prophylaxis with pneumatic compression devices both intraop-
eratively and postoperatively and early postoperative ambulation 
are recommended. There are no data regarding use of  unfraction-
ated or low molecular weight heparin for prophylaxis in pregnant 
patients undergoing laparoscopy, though its use has been sug-
gested in patients undergoing extended major operations [42]. In 
patients who require anticoagulation during pregnancy, heparin 
has proven safe and is the agent of  choice [43].
Perioperative Care
Fetal Heart Monitoring
While intraoperative fetal heart rate monitoring was once thought 
to be the most accurate method to detect fetal distress during 
laparoscopy, no intraoperative fetal heart rate abnormalities have 
been reported in the literature [12]. This has led some to rec-
ommend preoperative and postoperative monitoring of  the fetal 
heart rate with no increased fetal morbidity having been reported. 
[13, 15].
Obstetrical Consultation
Maternal and fetal monitoring should be part of  any pregnant 
patient’s care and continue throughout her hospitalization, but 
the timing of  a formal obstetric consultation will vary based on 
availability of  the consultant and the severity of  the patient’s con-
dition. Delaying the treatment of  an acute abdominal process to 
obtain such a consultation should be avoided as treatment delay 
may increase the risk of  morbidity and mortality to the mother 
and fetus [44].
Tocolytics
Tocolytics should not be used prophylactically in pregnant wom-
en undergoing surgery but should be considered perioperatively 
when signs of  Threatened preterm labor are present. The specific 
agent and indications for the use of  tocolytics should be individu-
alized and based on the recommendation of  an obstetrician [45]. 
No literature supports the use of  prophylactic tocolytics.
Anesthetic drugs in pregnancy
In general, pregnancy does not affect the choice of  medications, 
or their doses; however, pregnant women are more sensitive to 
the effects of  some anesthetic agents, so neuromuscular blockade 
and effects of  volatile anesthetics should be monitored.
Anesthetic dosing
Induction agents: Induction dose of  propofol is unchanged in preg-
nancy [46]. The induction dose of  thiopental is decreased in preg-
nancy by 18 to 35 percent [47].
Neuromuscular blockers: Pregnant patients are more sensitive to the 
action of  vecuronium and rocuronium [48], but have increased 
clearance of  both of  these medications [49]. Succinylcholine dose 
is unchanged in pregnancy; its volume of  distribution is increased, 
but systemic pseudocholinesterase activity is decreased [50, 51], 
resulting in variability in duration of  action. Pregnant women de-
velop less prominent fasciculation, but more prominent bradycar-
dia in response to succinylcholine.
Volatile anesthetics: The MAC for volatile anesthetic agents is de-
creased by about to 30 percent, beginning in the first trimester 
[52, 53].
Uterine-effects: Potent inhalational agents, such as isoflurane, des-
flurane, and sevoflurane decrease uterine tone; thus, they act to 
inhibit labor during the operative procedure [54]. Inhaled nitrous 
oxide (either alone or as a 50 percent mixture with oxygen) has 
no effect on uterine tone, maternal hemodynamic status, or fetal 
heart rate variability [55].
Summary
Laparoscopy results in multiple postoperative benefits allowing 
for quicker recovery and shorter hospital stay. These advantages 
explain the increasing success of  laparoscopy, which is recom-
mended for many surgical procedures. Improved knowledge of  
the intraoperative repercussions of  laparoscopy permits safe 
management of  patients with more and more severe cardiores-
piratory disease, who may subsequently benefit from the multiple 
postoperative advantages offered by this technique. The most re-
markable concerns regarding anaesthesia in laparoscopic proce-
dures are:
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1. Avoid or minimize aortocaval compression.
2. Perform surgery in the second trimester where possible. 
Avoid elective surgery until after delivery.
3. Maintain normal maternal physiology. Optimize uteropla-
cental perfusion and avoid fetal asphyxia.
4. Avoid unwanted drug effects on the fetus, but be aware that 
no anaesthetic agents have been shown to be teratogenic in 
the clinical use.
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